GLP-1 Weight Loss
Mino GLP2-T
Tirzepatide — active ingredient
Compounded Tirzepatide · Mounjaro / Zepbound class
Dual GIP/GLP-1 agonist for enhanced weight loss and blood sugar control.
Overview
Tirzepatide is a dual agonist that activates both GIP and GLP-1 receptors, often producing greater weight loss than GLP-1-only medications. It is a leading option for patients with higher BMI or strong weight-loss goals.
At Mino MD, tirzepatide is prescribed after physician review and dispensed through a U.S. compounding pharmacy with a gradual titration schedule to support tolerability.
How it works
By engaging two complementary gut-hormone pathways (GIP and GLP-1), tirzepatide reduces appetite, improves insulin sensitivity, and slows gastric emptying — a combination that can drive substantial, sustained weight loss.
Benefits
- Among the most effective medical weight-loss options available
- Dual-pathway action on appetite and blood sugar
- Once-weekly injection
- Strong results for higher-BMI patients
- Gradual titration to 15mg to manage side effects
Dosing
Treatment typically starts at 2.5mg once weekly and increases every four weeks toward a target of up to 15mg as tolerated. A 5mg maintenance protocol is available for patients already stable on therapy.
Who it's for
Generally appropriate for adults with a BMI of 30+ , or 27+ with a weight-related condition. The same guided H&P and AI contraindication screen used for all GLP-1 therapies applies, ruling out medullary thyroid carcinoma, MEN2, pregnancy, and other contraindications.
Possible side effects
- Nausea or decreased appetite, especially during titration
- Diarrhea or constipation
- Indigestion or fatigue
- Most effects are dose-related and improve over time
Frequently asked questions
Is tirzepatide more effective than semaglutide?
In head-to-head clinical research, tirzepatide produced greater average weight loss than semaglutide for many patients. Your physician will recommend the option best suited to your health profile and goals.
How is tirzepatide taken?
It is a once-weekly subcutaneous injection. You rotate injection sites and follow the titration schedule your physician sets.
Can I switch from semaglutide to tirzepatide?
Often yes. Many patients transition between GLP-1 therapies under physician guidance. Your provider will determine an appropriate starting dose when switching.
Is compounded tirzepatide safe?
Compounded tirzepatide is prepared by licensed U.S. compounding pharmacies. As with any prescription, it should only be used under physician supervision after a proper evaluation.